Terms: = Breast cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL
225 results:
1. Genetic and clinical landscape of ER + /PR- breast cancer in China.
Dai D; Wu H; Zhuang H; Chen R; Long C; Chen B
BMC Cancer; 2023 Dec; 23(1):1189. PubMed ID: 38049758
[TBL] [Abstract] [Full Text] [Related]
2. Secretory Carcinoma with etv6-NTRK3 Gene Fusion and Lymph Node Metastasis in Maxillary Gingiva: A Case Report with Pathological and Molecular Correlative Studies.
Fujita J; Krishnan B; Green LK; Sandulache VC; Lai S
Ann Clin Lab Sci; 2023 Sep; 53(5):800-805. PubMed ID: 37945013
[TBL] [Abstract] [Full Text] [Related]
3. Utility of MUC4 in the diagnosis of secretory carcinoma of salivary glands.
Fatima S; Ahmed A; Suleman S; Din NU
Ann Diagn Pathol; 2023 Dec; 67():152220. PubMed ID: 37924657
[TBL] [Abstract] [Full Text] [Related]
4. Salivary Gland Secretory Carcinoma; Review of 13 Years World-Wide Experience and Meta-Analysis.
Yosefof E; Boldes T; Dan D; Robenshtok E; Strenov Y; Bachar G; Shpitzer T; Mizrachi A
Laryngoscope; 2024 Apr; 134(4):1716-1724. PubMed ID: 37909690
[TBL] [Abstract] [Full Text] [Related]
5. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
Zhao YY; Ge HJ; Yang WT; Shao ZM; Hao S
Breast Cancer Res Treat; 2024 Feb; 203(3):543-551. PubMed ID: 37897648
[TBL] [Abstract] [Full Text] [Related]
6. A case report and literature review on a rare subtype of triple-negative breast cancer in children.
Shi L; Zhang Y; Wu J; Li J; Zhu J; Xu Y; Li N; Li Q; Zhang W
BMC Pediatr; 2023 Sep; 23(1):494. PubMed ID: 37773118
[TBL] [Abstract] [Full Text] [Related]
7. Secretory carcinoma of salivary glands with NTRK3 break-apart molecular rearrangement: Potential misdiagnosis with mucoepidermoid carcinoma.
Nocini R; Sanna G; Trotolo A; Fior A; Brunelli M; Manfrin E; Favero V
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101635. PubMed ID: 37709146
[TBL] [Abstract] [Full Text] [Related]
8. Secretory breast cancer in a boy: A case report with genetic analysis using next-generation sequencing and literature review.
Deng L; Li Y; Zhong J
Medicine (Baltimore); 2023 Jul; 102(27):e34192. PubMed ID: 37417596
[TBL] [Abstract] [Full Text] [Related]
9. High-grade non-intestinal type sinonasal adenocarcinoma with etv6::NTRK3 fusion, distinct from secretory carcinoma by immunoprofile and morphology.
Klubíčková N; Mosaieby E; Ptáková N; Trinquet A; Laé M; Costes-Martineau V; Skálová A
Virchows Arch; 2023 Aug; 483(2):187-195. PubMed ID: 37415052
[TBL] [Abstract] [Full Text] [Related]
10. Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System.
Baněčková M; Thompson LDR; Hyrcza MD; Vaněček T; Agaimy A; Laco J; Simpson RHW; Di Palma S; Stevens TM; Brcic L; Etebarian A; Dimnik K; Majewska H; Stárek I; O'Regan E; Salviato T; Helliwell T; Horáková M; Biernat W; Onyuma T; Michal M; Leivo I; Skalova A
Am J Surg Pathol; 2023 Jun; 47(6):661-677. PubMed ID: 37070739
[TBL] [Abstract] [Full Text] [Related]
11. Fluorescence in situ hybridization for etv6 gene rearrangements on destained cytological smears: Role in diagnosis of secretory carcinoma of salivary gland.
Mahendru R; Sarma C; Kakkar A; Kumar R; Kaur K; Thakar A
Cancer Cytopathol; 2023 Jul; 131(7):442-453. PubMed ID: 36973972
[TBL] [Abstract] [Full Text] [Related]
12. Real-world experience of tropomyosin receptor kinase inhibition with entrectinib in etv6-NTRK3 positive metastatic salivary secretory carcinoma: A case series.
Yokota T; Yukino H; Doi M; Ohori H
Head Neck; 2023 May; 45(5):E10-E15. PubMed ID: 36924196
[TBL] [Abstract] [Full Text] [Related]
13. The impact of subjective image quality evaluation in mammography.
Alukić E; Homar K; Pavić M; Žibert J; Mekiš N
Radiography (Lond); 2023 May; 29(3):526-532. PubMed ID: 36913787
[TBL] [Abstract] [Full Text] [Related]
14. Approaches to the diagnosis of secretory carcinoma of the salivary glands: a case series and review.
Hermann CR; Gama-Cuellar AG; Díaz KP; Gondak R
Gen Dent; 2023; 71(2):23-27. PubMed ID: 36825969
[TBL] [Abstract] [Full Text] [Related]
15. A challenging diagnosis of mammary analogue secretory carcinoma (MASC) on fine needle aspiration cytology and cell block: A cytopathologist's perspective.
Saraf P; Bharti JN; Malik A
Cytopathology; 2023 Jul; 34(4):377-380. PubMed ID: 36825352
[TBL] [Abstract] [Full Text] [Related]
16. Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitors.
Lassche G; van Engen-van Grunsven ACH; van Hooij O; Aalders TW; Am Weijers J; Cocco E; Drilon A; Hoischen A; Neveling K; Schalken JA; Verhaegh GW; van Herpen CML
Oral Oncol; 2023 Feb; 137():106297. PubMed ID: 36610231
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features.
Lei T; Yang Y; Shi Y; Deng X; Peng Y; Wang H; Chen T
Diagn Pathol; 2022 Dec; 17(1):101. PubMed ID: 36585729
[TBL] [Abstract] [Full Text] [Related]
18. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
[TBL] [Abstract] [Full Text] [Related]
19. Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL Inhibitors.
Chan S; Zhang Y; Wang J; Yu Q; Peng X; Zou J; Zhou L; Tan L; Duan Y; Zhou Y; Hur H; Ai J; Wang Z; Ren X; Zhang Z; Ding K
J Med Chem; 2022 Nov; 65(22):15374-15390. PubMed ID: 36358010
[TBL] [Abstract] [Full Text] [Related]
20. Virtual Biopsy by Using Artificial Intelligence-based Multimodal Modeling of Binational Mammography Data.
Barros V; Tlusty T; Barkan E; Hexter E; Gruen D; Guindy M; Rosen-Zvi M
Radiology; 2023 Mar; 306(3):e220027. PubMed ID: 36283109
[TBL] [Abstract] [Full Text] [Related]
[Next]
